These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36419062)

  • 1. Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.
    Mhazo AT; Maponga CC
    BMC Health Serv Res; 2022 Nov; 22(1):1390. PubMed ID: 36419062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    PLoS One; 2019; 14(6):e0215577. PubMed ID: 31251737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii48-iii57. PubMed ID: 31816073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators.
    Perehudoff K
    Glob Health Action; 2020 Dec; 13(1):1699342. PubMed ID: 33131456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agenda setting for essential medicines policy in sub-Saharan Africa: a retrospective policy analysis using Kingdon's multiple streams model.
    Mhazo AT; Maponga CC
    Health Res Policy Syst; 2021 May; 19(1):72. PubMed ID: 33941199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana.
    Koduah A
    Front Public Health; 2023; 11():1163342. PubMed ID: 37483923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The political economy of universal health coverage: a systematic narrative review.
    Rizvi SS; Douglas R; Williams OD; Hill PS
    Health Policy Plan; 2020 Apr; 35(3):364-372. PubMed ID: 31904858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia.
    Hasnida A; Kok MO; Pisani E
    BMJ Glob Health; 2021 May; 6(Suppl 3):. PubMed ID: 34049935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncommunicable diseases, access to essential medicines and universal health coverage.
    Beran D; Pedersen HB; Robertson J
    Glob Health Action; 2019; 12(1):1670014. PubMed ID: 31573421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framing and the health policy process: a scoping review.
    Koon AD; Hawkins B; Mayhew SH
    Health Policy Plan; 2016 Jul; 31(6):801-16. PubMed ID: 26873903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
    Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
    BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.
    Amimo F; Lambert B; Magit A; Hashizume M
    Global Health; 2021 Apr; 17(1):42. PubMed ID: 33832487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality use of medicines within universal health coverage: challenges and opportunities.
    Wagner AK; Quick JD; Ross-Degnan D
    BMC Health Serv Res; 2014 Aug; 14():357. PubMed ID: 25164588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successes and challenges of health systems governance towards universal health coverage and global health security: a narrative review and synthesis of the literature.
    Debie A; Khatri RB; Assefa Y
    Health Res Policy Syst; 2022 May; 20(1):50. PubMed ID: 35501898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How is equity approached in universal health coverage? An analysis of global and country policy documents in Benin and Senegal.
    Paul E; Deville C; Bodson O; Sambiéni NE; Thiam I; Bourgeois M; Ridde V; Fecher F
    Int J Equity Health; 2019 Dec; 18(1):195. PubMed ID: 31847877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of prioritizing politics in Good Governance for Medicines Initiative in Zimbabwe: a qualitative policy analysis study.
    Mhazo AT; Maponga CC
    Health Policy Plan; 2022 May; 37(5):634-643. PubMed ID: 35106585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling the blind spot of poor-quality medicines in Universal Health Coverage.
    Orubu ESF; Ching C; Zaman MH; Wirtz VJ
    J Pharm Policy Pract; 2020; 13():40. PubMed ID: 32670594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Realist evaluation of the role of the Universal Health Coverage Partnership in strengthening policy dialogue for health planning and financing: a protocol.
    Robert E; Ridde V; Rajan D; Sam O; Dravé M; Porignon D
    BMJ Open; 2019 Jan; 9(1):e022345. PubMed ID: 30782678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health workforce policy and plan implementation in the context of universal health coverage in the Africa Region.
    Ahmat A; Okoroafor SC; Asamani JA; Dovlo D; Millogo JJS; Abdou Illou MM; Nyoni J
    BMJ Glob Health; 2022 May; 7(Suppl 1):. PubMed ID: 35589141
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.